Anzeige
Mehr »
Login
Mittwoch, 25.09.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Diese Firma hat die Grundlagen, um zu einem Goldkraftwerk zu werden!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EXPE | ISIN: CA8529191097 | Ticker-Symbol: FE0
Frankfurt
25.09.24
08:14 Uhr
0,044 Euro
0,000
0,00 %
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
STALLION URANIUM CORP Chart 1 Jahr
5-Tage-Chart
STALLION URANIUM CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,0440,05612:21
0,0440,05608:15
GlobeNewswire (Europe)
64 Leser
Artikel bewerten:
(0)

Stallion Uranium Corp.: Stallion Uranium Strategically Expands Largest Land Package in the Prolific Southwestern Athabasca Basin

VANCOUVER, British Columbia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the "Company" or "Stallion") (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to announce that it has acquired by low-cost staking ten new prospective uranium exploration dispositions (or "claims"). The new claims will make up the Company's Stone Island Project, covering 9,993 hectares and further bolstering Stallion's land package in the prolific Southwestern Athabasca Basin. The new dispositions are contiguous to the Western Athabasca Basin JV Project (Stallion and Atha Energy) and are 100% owned by Stallion Uranium.

Key Exploration Highlights

  • Staked 9,993 ha of contiguous claims
  • New dispositions host the extension of Stallion's Coyote Corridor
  • Shallow depth to Unconformity of 100-400m
  • Hosts the extensions of known additional conductive trends

"Highly prospective land in the Athabasca basin very rarely becomes available," said CEO Drew Zimmerman "We are fortunate to have been able to stake such a large land package in a very competitive area. These newly acquired claims are geologically prospective and strategically located along our existing land package allowing Stallion to more easily integrate the project into our proven exploration funnel."

New Mineral Dispositions - The Stone Island Project

The new project is located on the southern edge of Stallion's Western Athabasca Basin JV Project. In a very competitive and prospective area, Stallion was able to stake 9,993 ha of land hosted across 10 mineral claims. The project hosts the extension of Stallion's previously identified and highly prospective Coyote Corridor as well as other historically identified conductors. The project is located the Taltson Geological Domain which hosts the NexGen's Arrow deposit.

Stallion will begin the process of having this additional project go through the Company's exploration funnel. A technologically advanced exploration process that efficiently and effectively uncovers the highest priority target areas on the project for further advancement. With proprietary data available from work the company has already completed on adjoining projects, the company sees incredible potential in the Stone Island Project.

Darren Slugoski, Vice President Exploration stated, "We are extremely happy to be able to secure the land acquisition covering such a highly prospective area in the Southwest Athabasca Basin. Our technical team is focused entirely on the underexplored Southwestern Athabasca Basin and our knowledge of the area allowed us to identify and acquire the highly prospective ground containing both recently discovered and historical conductive corridors. Given the prospective data from our contiguous land package, we look forward to incorporating the Stone Island project into our exploration programs."

Stallion's Newly Staked 9,993ha Stone Island Project

Figure 1 - Stallion's Newly Staked 9,993ha Stone Island Project

Qualifying Statement

The foregoing scientific and technical disclosures for Stallion Uranium have been reviewed by Darren Slugoski, P.Geo., VP Exploration, a registered member of the Professional Engineers and Geoscientists of Saskatchewan. Mr. Slugoski is a Qualified Person as defined by National Instrument 43-101.

About Stallion Uranium

Stallion Uranium is working to 'Fuel the Future with Uranium' through the exploration of over 3,000 sq/km in the Athabasca Basin, home to the largest high-grade uranium deposits in the world. The company, with JV partner Atha Energy holds the largest contiguous project in the Western Athabasca Basin adjacent to multiple high-grade discovery zones.

Our leadership and advisory teams are comprised of uranium and precious metals exploration experts with the capital markets experience and the technical talent for acquiring and exploring early-stage properties.

Stallion offers optionality with the Horse Heaven gold project in Idaho that neighbours the world class Stibnite Gold deposit held by Perpetua Resources, offering exposure to upside potential from district advancement with limited capital expenditures.

For more information visit stallionuranium.com or contact:

Drew Zimmerman
Chief Executive Officer
778-686-0973
info@stallionuranium.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking statements and forward-looking information within the meaning of Canadian securities legislation (collectively, "forward-looking statements") that relate to the Company's current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as "will likely result", "are expected to", "expects", "will continue", "is anticipated", "anticipates", "believes", "estimated", "intends", "plans", "forecast", "projection", "strategy", "objective" and "outlook") are not historical facts and may be forward-looking statements and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward-looking statements. No assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this material change report should not be unduly relied upon. These statements speak only as of the date they are made.

Forward-looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond the Company's control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for the Company to predict all of them, or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. Any forward-looking statements contained in this presentation are expressly qualified in their entirety by this cautionary statement.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2fb3e80c-d225-48f8-b73e-f46edf04c1e5


© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.